Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Tonix Pharmaceuticals Holding (TNXP) Work In Process (2023 - 2025)

Tonix Pharmaceuticals Holding (TNXP) has 3 years of Work In Process data on record, last reported at $1.5 million in Q3 2025.

  • For Q3 2025, Work In Process fell 23.91% year-over-year to $1.5 million; the TTM value through Sep 2025 reached $1.5 million, down 23.91%, while the annual FY2024 figure was $213000.0, 91.61% down from the prior year.
  • Work In Process reached $1.5 million in Q3 2025 per TNXP's latest filing, up from $1.3 million in the prior quarter.
  • Across five years, Work In Process topped out at $2.5 million in Q4 2023 and bottomed at $213000.0 in Q4 2024.
  • Average Work In Process over 3 years is $1.4 million, with a median of $1.4 million recorded in 2025.
  • Peak YoY movement for Work In Process: tumbled 91.61% in 2024, then fell 23.91% in 2025.
  • A 3-year view of Work In Process shows it stood at $2.5 million in 2023, then crashed by 91.61% to $213000.0 in 2024, then surged by 597.65% to $1.5 million in 2025.
  • Per Business Quant database, its latest 3 readings for Work In Process were $1.5 million in Q3 2025, $1.3 million in Q2 2025, and $664000.0 in Q1 2025.